Towards Healthcare Research & Consulting
Biologics Market
Updated Date: 10 August 2026   |   Report Code: 5108
[email protected] +1 804-441-9344
Download Sample Order Now

Biologics Market Outlook, Size, Share and Growth Forecast 2035

According to Payal Rabde, who specializes in biopharmaceuticals, biotechnology, and healthcare market research, with 4+ years of experience in market research and industry analysis, this research indicates that the biologics market is set to grow from USD 522.06 billion in 2026 to USD 1009.33 billion by 2035 at a 7.6% CAGR, driven by rising demand for targeted therapies and continuous biotechnology innovation. His analysis identifies oncology, microbial-derived biologics, in-house manufacturing, and monoclonal antibodies as the leading market segments, while highlighting North America's market leadership and Asia-Pacific's rapid expansion. The study also evaluates the competitive strategies of major companies, including Amgen, Merck & Co., F. Hoffmann-La Roche, Bristol-Myers Squibb, Sanofi, Bayer, AstraZeneca, Novartis, and Eli Lilly, shaping the global biologics landscape.

Last Updated : 10 August 2026 Category: Biotechnology Insight Code: 5108 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Biologics Market Assessment

  • Overview
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house
  • Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Biologics Market Assessment

  • Overview
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Europe Biologics Market Assessment

  • Overview
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Asia Pacific Biologics Market Assessment

  • Overview
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Latin America Biologics Market Assessment

  • Overview
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Middle East and Africa Biologics Market Assessment

  • Overview
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Tissue and Tissue Products
    • Vaccines
    • Others Types
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Oncology
    • Immunology
    • Infectiuos Disease
    • Other Indications
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Diagnosis
    • Treatment
  • Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
    • Outsourced
    • In-house

Company Profiles

  • Amgen
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Merck & Co.
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb
  • Sanofi
  • Bayer AG
  • AstraZeneca
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Eli Lilly and Company

Conclusion & Recommendations

FAQ's

Answer : The biologics market is projected to grow from USD 522.06 billion in 2026 to USD 1009.33 billion by 2035, expanding at a CAGR of 7.6% due to rising chronic diseases and technological advancements.

Answer : Monoclonal antibodies dominated the market in 2024 due to their high specificity, longer half-life, fewer side effects, and increasing FDA approvals.

Answer : Food and Drug Administration, World Health Organization, American Cancer Society, ASCO.gov., National Institute of Biologics, CDSCO.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar